BFRI high analyst ratingsBFRI Biofrontera is a biopharmaceutical company which commercializes pharmaceutical products for the treatment of dermatological conditions in the U.S.
Benchmark brokerage Initiated Coverage on BFRI with a Buy rating and a price of $11.00
Roth Capital brokerage Initiated Coverage on BFRI with a Buy rating and a price of $20.00
Looking forward to read your opinion about it.
Stockstobuy
BHEL looks attractive and showing signals of trend reversal.BHEL is PSU which is into engineering and manufacturing capability across several core sectors, including power generation and transmission, transportation, renewables, water, oil & gas and defense & aerospace. X/2 Entry can be taken in BHEL at CMP and second SIP of X/2 entry can be taken above 57 closing. The target for BHEL will be 61.8 and 65.85. In a long run BHEL can even reach 70.5 if it is able to give an above par quarterly result or two. Stop loss should be maintained at closing below 44. It is a company with Zero Promoter pledge. MFs have increased their stake in BHEL in the last quarter or so.
HDFC is gaining excellent Tailwind.HDFC AMC is one of India’s premier asset management company with a Market cap of Rs.48552.9 Crores. Valuation wise it can be considered little expensive as it trades at a PE of 35.5 currently but the point to be noted here is that MFs, FIIs are increasing their stake in this company with no debt and Zero promoter pledge. Entry can be taken at CMP compounding can be done above 2337. The targets will be 2518 in the short to medium term. Long term target for HDFC AMC will be 2800+. Stop loss should be maintained at closing below 1990.
VRM 11X upside potential according to Bank of AmericaI`m back with a premium signal in my opinion!
Vroom, former Auto America, operates end-to-end ecommerce platform for buying, selling, transporting, reconditioning, pricing, financing, registering, and delivering vehicles in the United States.
On 2/3/2022 Bank of America Lowered the Price Target for Vroom, Inc. (VRM) from $65.00 to $30.00!
The stock is now $2.79!!!
12K calls expiring April 14 with a strike price of $5 for VRM!
BlackRock invested $193Mil in VRM at an average price of $41!!!
95.87% institutional ownership!
$350K insider buys this month!
3.18Bil revenue last year, Market Cap of only 382.57Mil!
I think a 3X from here is inevitable!
What is your opinion about it?
RSLS +500% upside potential according to this analyst RSLS, ReShape Lifesciences, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
On 11/12/2021 Anthony Vendetti from Maxim Group brokerage Reiterated the Buy Rating for RSLS with a price target of $8.00.
That is more that 5X from the current price.
Looking forward to read your opinion about it.
Nvidia Stock NVDA Is Edging HigherNvidia stock NVDA had built a strong move on Friday to post a solid gains of 6.81% and close on the resistance area around $265.00.
The stock is showing bottoming signals after violating the downward trendline, Prices have the potential to test the 50.00% and 61.80% Fibonacci Retracement levels ($276.00 - $293.00) consecutively.
It is worth mentioning that Nvidia's investors’ day event - between March 21-24 - will be watched closely across the tech sector and will boost the price's volatility.
Reliance might be in the zone from where it go/grow stronger Reliance is trying to come out of the squeezing triangle and is making the case for fresh entry above 2503 closing. The medium term target will be 2597 and the long term target will be 2700+. Reliance is a buy on dip and bounce candidate and also a Portfolio stock being India’s one of the premier companies. However for trading purpose if someone wants to keep a stop loss they should keep it at closing below 2175. Reliance is into Oil and Gas, Retail, telecom, Green energy and textile all together. Scope of value unlocking in the share is huge owing to the diversity of segments the company caters to. By all means the stock has potential to become a long term asset creator. One down side of the stock is that it trades at a expensive valuations of 29.1 currently. For Paper trading. Educational view only.
Coromandel looking stronger by every passing dayCoromandel International has given a strong Break out with good volumes. The company has strong presence in fertilizers, specialty nutrients, organic fertilizers, crop- protection and bio-pesticides. PE ratio of the company is little bit on the upper side currently at 17.9. Market cap of the company is Rs. 24,931 Crores. Entry now can be taken above 862 closing and the targets will be 888 and 923. A stop loss should be maintained at closing below 700. The stock can also be added on bounce between 775 and 800 if it dips a bit. Educational purpose only. For Paper Trading.
PALI +500% potential according to this analystPalisade Bio, Inc. (PALI) plans to initiate a phase 3 study for accelerating the return of bowel function in the first half of 2022 and for the first patient to be enrolled in the second half of 2022.
On 2/2/2022 LADENBURG THALM/SH SH brokerage Initiated Coverage for PALI with a Buy rating and $5.00 Price Target.
Market Cap 12.841Mil
52 Week Range 0.76 - 16.02
I think this stock can easily double in price this year.
GROM Social reversal targetsGrom Social Enterprises operates as a media, technology, and entertainment company that focuses on delivering content in the U.S.
On 1/13/2022 UBS Group Initiated Coverage of GROM with a Buy rating.
Back then the price was $1.8, now it`s half the price.
I think it can easily reach January's price and go even further, to $2.70.